Literature DB >> 24452835

Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban.

Andrea Messori1, Dario Maratea, Valeria Fadda, Sabrina Trippoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24452835     DOI： 10.1007/s00228-014-1644-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Some problems with the investigation of noninferiority in meta-analysis.

Authors:  S Witte; N Victor
Journal:  Methods Inf Med       Date:  2004       Impact factor: 2.176

2.  Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli; Claudio Marinai
Journal:  Clin Infect Dis       Date:  2013-10-17       Impact factor: 9.079

3.  No evidence of efficacy or evidence of no efficacy.

Authors:  Marco A Arruda
Journal:  JAMA Pediatr       Date:  2013-03-01       Impact factor: 16.193

4.  How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research.

Authors:  Soyeon Ahn; Seong Ho Park; Kyoung Ho Lee
Journal:  Radiology       Date:  2013-05       Impact factor: 11.105

5.  New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation.

Authors:  Saurav Chatterjee; Partha Sardar; Giuseppe Biondi-Zoccai; Dharam J Kumbhani
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

6.  Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.

Authors:  Gregory Y H Lip; Torben Bjerregaard Larsen; Flemming Skjøth; Lars Hvilsted Rasmussen
Journal:  J Am Coll Cardiol       Date:  2012-05-09       Impact factor: 24.094
  6 in total
  2 in total

1.  Biological drugs for the treatment of moderate-to-severe psoriasis by subcutaneous route: determining statistical equivalence according to evidence-based methods.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli; Roberta Gatto; Mauro De Rosa; Claudio Marinai
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

2.  Biological drugs for inducing remission in patients with Crohn's disease: determining statistical equivalence according to evidence-based methods.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli; Claudio Marinai
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.